Alessandra Iurlo

8.5k total citations
157 papers, 2.1k citations indexed

About

Alessandra Iurlo is a scholar working on Hematology, Genetics and Rheumatology. According to data from OpenAlex, Alessandra Iurlo has authored 157 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 120 papers in Hematology, 119 papers in Genetics and 53 papers in Rheumatology. Recurrent topics in Alessandra Iurlo's work include Chronic Myeloid Leukemia Treatments (84 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (74 papers) and Eosinophilic Disorders and Syndromes (53 papers). Alessandra Iurlo is often cited by papers focused on Chronic Myeloid Leukemia Treatments (84 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (74 papers) and Eosinophilic Disorders and Syndromes (53 papers). Alessandra Iurlo collaborates with scholars based in Italy, United States and Spain. Alessandra Iurlo's co-authors include Daniele Cattaneo, Umberto Gianelli, Elisa Fermo, Massimo Breccia, Cristina Bucelli, Paola Bianchi, Alberto Zanella, Agostino Cortelezzi, Carla Boschetti and Claudia Vener and has published in prestigious journals such as The Journal of Experimental Medicine, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Alessandra Iurlo

147 papers receiving 2.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Alessandra Iurlo Italy	27	1.3k	1.3k	598	584	180	157	2.1k
Brady L. Stein United States	25	1.2k 0.9×	985 0.8×	808 1.4×	578 1.0×	81 0.5×	105	2.1k
Jan Samuelsson Sweden	26	1.9k 1.4×	1.9k 1.5×	1.2k 1.9×	682 1.2×	86 0.5×	75	2.8k
Holger Cario Germany	19	890 0.7×	680 0.5×	440 0.7×	271 0.5×	224 1.2×	72	1.5k
Aaron T. Gerds United States	23	1.3k 1.0×	1.7k 1.3×	896 1.5×	359 0.6×	33 0.2×	260	2.4k
John Camoriano United States	27	946 0.7×	735 0.6×	714 1.2×	524 0.9×	371 2.1×	66	2.5k
Michelle A. Elliott United States	34	2.9k 2.2×	2.9k 2.2×	1.5k 2.5×	1.2k 2.1×	65 0.4×	138	4.4k
Prasheen Agarwal United States	16	510 0.4×	971 0.8×	99 0.2×	1.0k 1.8×	204 1.1×	29	1.7k
Luisa Ponchio Italy	18	644 0.5×	1000 0.8×	320 0.5×	70 0.1×	136 0.8×	47	1.8k
Douglas Schlichting United States	22	662 0.5×	1.1k 0.8×	209 0.3×	2.1k 3.6×	61 0.3×	33	2.8k
Joy Schechtman United States	11	360 0.3×	421 0.3×	198 0.3×	1.1k 1.8×	49 0.3×	17	1.7k

Countries citing papers authored by Alessandra Iurlo

Since Specialization

Citations

This map shows the geographic impact of Alessandra Iurlo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alessandra Iurlo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alessandra Iurlo more than expected).

Fields of papers citing papers by Alessandra Iurlo

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alessandra Iurlo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alessandra Iurlo. The network helps show where Alessandra Iurlo may publish in the future.

Co-authorship network of co-authors of Alessandra Iurlo

This figure shows the co-authorship network connecting the top 25 collaborators of Alessandra Iurlo. A scholar is included among the top collaborators of Alessandra Iurlo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alessandra Iurlo. Alessandra Iurlo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Barbui, Tiziano, Arianna Ghirardi, Victoria Empson, et al.. (2025). Neutrophil-to-Lymphocyte ratio as surrogate for JAK2V617F suppression and event-free survival in polycythemia vera. Blood Cancer Journal. 15(1). 132–132. 2 indexed citations

Biagioli, Valentina, Antonella Barone, Alessandra Iurlo, et al.. (2025). Validity and Reliability of the Self‐Care in MyeloProliferative Neoplasms Inventory (SC‐MPNI). European Journal of Cancer Care. 2025(1).

Watts, Justin M., Alessandro M. Vannucchi, Anthony M. Hunter, et al.. (2024). Bromodomain and extra-terminal (BET) inhibitor INCB057643 in patients with relapsed or refractory myelofibrosis (MF) and other advanced myeloid neoplasms: A phase 1 study.. Journal of Clinical Oncology. 42(16_suppl). 6576–6576. 1 indexed citations

Harrison, Claire, Ruben A. Mesa, Moshe Talpaz, et al.. (2024). Efficacy and safety of fedratinib in patients with myelofibrosis previously treated with ruxolitinib (FREEDOM2): results from a multicentre, open-label, randomised, controlled, phase 3 trial. The Lancet Haematology. 11(10). e729–e740. 11 indexed citations

Iurlo, Alessandra, Cristina Bucelli, Tamara Intermesoli, et al.. (2024). Bosutinib Treatment of Chronic Myeloid Leukemia in Lombardy. Acta Haematologica. 148(4). 494–498. 1 indexed citations

Lopez, Gianluca, et al.. (2023). The molecular landscape of myeloproliferative neoplasms associated with splanchnic vein thrombosis: Current perspective. Leukemia Research. 136. 107420–107420. 4 indexed citations

Breccia, Massimo, Alfonso Piciocchi, Elisabetta Abruzzese, et al.. (2023). Italian Physicians’ Perceptions about the Role of Asciminib in Later Lines Chronic Myeloid Leukemia in Clinical Practice: A GIMEMA Survey. Journal of Clinical Medicine. 12(16). 5267–5267. 1 indexed citations

Iurlo, Alessandra, Cristina Bucelli, & Daniele Cattaneo. (2023). Essential Thrombocythemia in Adolescents and Young Adults: Clinical Aspects, Treatment Options and Unmet Medical Needs. Current Treatment Options in Oncology. 24(7). 802–820. 2 indexed citations

Cattaneo, Daniele, Cristina Bucelli, Alfredo Marchetti, et al.. (2023). Pathological and genomic features of myeloproliferative neoplasms associated with splanchnic vein thrombosis in a single-center cohort. Annals of Hematology. 102(6). 1409–1420. 9 indexed citations

10.

Croci, Giorgio Alberto, et al.. (2023). Lymphomatoid papulosis associated with myeloid neoplasm with eosinophilia and FIP1L1::PDGFRA rearrangement: Successful imatinib treatment in two cases. The Journal of Dermatology. 50(10). 1330–1334. 2 indexed citations

11.

Gisslinger, Heinz, Valerio De Stefano, Vincenzo Accurso, et al.. (2023). Ruxolitinib in patients with polycythemia vera resistant and/or intolerant to hydroxyurea: European observational study. European Journal Of Haematology. 112(3). 379–391. 1 indexed citations

12.

Gualtierotti, Roberta, et al.. (2022). Successful Chemical Synovectomy in a Patient with Acquired von Willebrand Syndrome with Chronic Synovitis Due to Recurrent Knee Hemarthrosis: A Case Report. Rheumatology and Therapy. 9(5). 1465–1474. 1 indexed citations

13.

Breccia, Massimo, Francesca Palandri, Paola Guglielmelli, et al.. (2022). Management of Myelofibrosis during Treatment with Ruxolitinib: A Real-World Perspective in Case of Resistance and/or Intolerance. Current Oncology. 29(7). 4970–4980. 4 indexed citations

14.

Ferrucci, Silvia Mariel, Luisa Angileri, Simona Tavecchio, et al.. (2022). Elevation of peripheral blood eosinophils during dupilumab treatment for atopic dermatitis is associated with baseline comorbidities and development of facial redness dermatitis and ocular surface disease. Journal of Dermatological Treatment. 33(5). 2587–2592. 19 indexed citations

15.

Cutica, Ilaria, Silvia Riva, Ester Orlandi, et al.. (2022). Psychological Factors Affecting the Willingness to Accept a Possible Tyrosine Kinase Inhibitor (TKI) Discontinuation in Chronic Myeloid Leukaemia (CML) Patients. Patient Preference and Adherence. Volume 16. 2963–2975. 1 indexed citations

16.

Iurlo, Alessandra, et al.. (2020). A case report of tetanic crisis from acute severe hypocalcemia secondary to hypovitaminosis D: analysis of risk factors for vitamin D deficiency between 1 and 18 years. 4(6). 1 indexed citations

17.

Bucelli, Cristina, et al.. (2018). Osteolytic Lesions in Primary Myelofibrosis and Effect of Ruxolitinib Therapy: Report of a Case and Literature Review. Chemotherapy. 63(6). 340–344. 6 indexed citations

18.

Efficace, Fabio, Gianantonio Rosti, Massimo Breccia, et al.. (2015). The impact of comorbidity on health-related quality of life in elderly patients with chronic myeloid leukemia. Annals of Hematology. 95(2). 211–219. 15 indexed citations

19.

Fava, Carmen, Irene Dogliotti, Paola Berchialla, et al.. (2015). IMATINIB DISCONTINUATION IN CHRONIC MYELOID LEUKEMIA: A RETROSPECTIVE ANALYSIS ON PATIENTS IN CLINICAL PRACTICE. Haematologica. 100. 232–232. 1 indexed citations

20.

Vener, Claudia, Nicola Stefano Fracchiolla, Umberto Gianelli, et al.. (2007). Prognostic implications of the European consensus for grading of bone marrow fibrosis in chronic idiopathic myelofibrosis. Blood. 111(4). 1862–1865. 61 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact